RESEARCH TRIANGLE PARK, N.C., Oct. 24, 2017 -- JAGGAER, a leader in indirect and direct spend management solutions, is digitalizing the procurement process with its Procure-to-Pay (P2P) solution for The University of Texas at Dallas. UT-Dallas will integrate JAGGAER’s Accounts Payable Director solution with their existing eProcurement solution to enable the university to automate invoicing and leverage JAGGAER’s advanced procurement workflow.
“It was an easy decision to choose JAGGAER based on our experience with Spend Director’s user-friendly interface and fast implementation. JAGGAER successfully automated our manual, paper-based processes and improved purchase order digitalization by over 50%. We look forward to seamlessly integrating JAGGAER’s P2P solutions suite with third-party purchasing sites to track and analyze all of our spend, which we weren’t able to do before,” said Debbie Reynolds, CPCP, CTPM, Procurement Management – Executive Director at The University of Texas at Dallas.
“We’re excited to help UT-Dallas achieve their procurement goals. JAGGAER’s P2P suite will enable end-to-end visibility and help them track and analyze spend for more efficient, intelligent purchasing decisions and ROI,” said Robert Bonavito, CEO of JAGGAER. “Our advanced dynamic workflow continues to enhance procurement processes for our customers, maximizing time and cost savings for their organizations.”
About JAGGAER: Global Indirect and Direct Spend Management Solutions
JAGGAER offers the only comprehensive and complete spend solution suites enabling commerce between any businesses, anywhere. We pioneered spend solutions over two decades ago and have continued to lead the innovation curve by listening to customers and analyzing the market. Our solutions suites are trusted by the world's largest education, manufacturing, pharmaceutical, life sciences, automotive, engineering, construction equipment, and medical technology companies and organizations. Our indirect and direct spend solutions suites collectively form a global network processing billions of dollars in annual spend between 1,100+ customers and 2.5 million suppliers. JAGGAER’s SaaS based, Source-to-Pay (S2P) solutions enable an efficient relationship between buyers and suppliers, covering the entire spectrum of needs, from spend analysis to sourcing through contract and supplier relationship management. Additionally, JAGGAER holds 38 patents--more than any other spend management company. Learn how our solutions can power your organization. www.JAGGAER.com
To join the conversation, please visit our blog at https://JAGGAER.com/blog/ or follow us on Twitter @JaggaerPro.
JAGGAER Presents REV2018: Educate – Innovate – Accelerate
Join us for our annual conference: JAGGAER.com/REV/
MEDIA CONTACT
[email protected]
919-659-NEWS


Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
Chevron Seeks Expanded U.S. License to Boost Venezuelan Oil Exports Amid Sanctions Talks
Hyundai Motor Shares Surge on Nvidia Partnership Speculation
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom
xAI Cash Burn Highlights the High Cost of Competing in Generative AI
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid
Avelo Airlines to End DHS Deportation Flights and Close Arizona Base Amid Rising Costs
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 



